As an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, retatrutide is not currently approved in the UK and remains available only within authorised clinical trials
Eli Lilly announced the topline results in December 2025: in obese participants with knee osteoarthritis, the 12 mg dose delivered a mean weight loss of 28,7% (32,3 kg / 71,2 lbs) at 68 weeks, and the 9 mg dose delivered a 26,4% reduction
These are examples of the best drinks for weight loss on GLP-1 because they provide energy without sabotaging your calorie deficit
If you choose to use a GLP-1, Im going to help you navigate your diet with science-backed info
How to Manage Semaglutide Headache Symptoms Effective headache management requires a systematic approach
After your virtual appointment, youll have an in-person visit at your home or workplace